Vincent Medical Holdings Management
Management criteria checks 3/4
Vincent Medical Holdings' CEO is Raymond Choi, appointed in Jan 2023, has a tenure of 1.92 years. total yearly compensation is HK$1.52M, comprised of 80.8% salary and 19.2% bonuses, including company stock and options. directly owns 1.48% of the company’s shares, worth HK$3.83M. The average tenure of the management team and the board of directors is 2.7 years and 8.5 years respectively.
Key information
Raymond Choi
Chief executive officer
HK$1.5m
Total compensation
| CEO salary percentage | 80.8% |
| CEO tenure | 1.9yrs |
| CEO ownership | 1.5% |
| Management average tenure | 2.7yrs |
| Board average tenure | 8.5yrs |
Recent management updates
Recent updates
Vincent Medical Holdings Limited's (HKG:1612) Shares Lagging The Market But So Is The Business
Oct 04
Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
Aug 23Investors Met With Slowing Returns on Capital At Vincent Medical Holdings (HKG:1612)
May 21Returns On Capital Are Showing Encouraging Signs At Vincent Medical Holdings (HKG:1612)
Dec 21Vincent Medical Holdings (HKG:1612) Is Experiencing Growth In Returns On Capital
Aug 29Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
May 30Is Vincent Medical Holdings (HKG:1612) Using Too Much Debt?
Dec 15One Analyst Thinks Vincent Medical Holdings Limited's (HKG:1612) Revenues Are Under Threat
Aug 07Vincent Medical Holdings' (HKG:1612) Returns Have Hit A Wall
Aug 06Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025
May 25Vincent Medical Holdings' (HKG:1612) Dividend Will Be Reduced To HK$0.025
Apr 27Vincent Medical Holdings (HKG:1612) Will Pay A Smaller Dividend Than Last Year
Apr 07Under The Bonnet, Vincent Medical Holdings' (HKG:1612) Returns Look Impressive
Mar 08Downgrade: Here's How This Analyst Sees Vincent Medical Holdings Limited (HKG:1612) Performing In The Near Term
Jul 27Is Vincent Medical Holdings (HKG:1612) A Risky Investment?
Jun 06One Vincent Medical Holdings Limited (HKG:1612) Analyst Just Slashed Their Estimates By A Material 13%
Mar 28Vincent Medical Holdings Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Mar 25Vincent Medical Holdings (HKG:1612) Knows How To Allocate Capital
Mar 23Have Insiders Been Buying Vincent Medical Holdings Limited (HKG:1612) Shares This Year?
Mar 04I Ran A Stock Scan For Earnings Growth And Vincent Medical Holdings (HKG:1612) Passed With Ease
Feb 17Is There An Opportunity With Vincent Medical Holdings Limited's (HKG:1612) 42% Undervaluation?
Feb 04
What You Need To Know About Vincent Medical Holdings Limited's (HKG:1612) Investor Composition
Jan 22Investors Who Bought Vincent Medical Holdings (HKG:1612) Shares A Year Ago Are Now Up 267%
Jan 08Has Vincent Medical Holdings Limited's (HKG:1612) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 26What We Learned About Vincent Medical Holdings' (HKG:1612) CEO Compensation
Dec 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | HK$64m |
| Mar 31 2024 | n/a | n/a | HK$61m |
| Dec 31 2023 | HK$2m | HK$1m | HK$57m |
Compensation vs Market: Raymond's total compensation ($USD194.84K) is about average for companies of similar size in the Hong Kong market ($USD230.70K).
Compensation vs Earnings: Insufficient data to compare Raymond's compensation with company performance.
CEO
Raymond Choi (41 yo)
1.9yrs
Tenure
HK$1,515,000
Compensation
Mr. Cheung Tai Choi, also known as Raymond, served as Deputy Chief Executive Officer of Vincent Medical Holdings Limited since January 1, 2022 until January 1, 2023 and serves as its Chief Executive Office...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 9.1yrs | HK$1.49m | 1.68% HK$ 4.3m | |
| CEO & Executive Director | 1.9yrs | HK$1.52m | 1.48% HK$ 3.8m | |
| VP of OEM Business & Executive Director | no data | HK$1.47m | 0.78% HK$ 2.0m | |
| Executive Director | no data | HK$1.42m | 0.93% HK$ 2.4m | |
| Chief Financial Officer | no data | no data | no data | |
| Associate Director of Operations | no data | no data | no data | |
| Vice President of Sales & Marketing | no data | no data | no data | |
| Head of Corporate Sustainability & Development | no data | no data | no data | |
| Head of Sales & Marketing of Greater China | 2.7yrs | no data | no data | |
| Company Secretary | 7.6yrs | no data | no data |
2.7yrs
Average Tenure
51yo
Average Age
Experienced Management: 1612's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 9.1yrs | HK$1.49m | 1.68% HK$ 4.3m | |
| CEO & Executive Director | 1.9yrs | HK$1.52m | 1.48% HK$ 3.8m | |
| VP of OEM Business & Executive Director | 8.8yrs | HK$1.47m | 0.78% HK$ 2.0m | |
| Executive Director | 8.8yrs | HK$1.42m | 0.93% HK$ 2.4m | |
| Independent Non-Executive Director | 8.5yrs | HK$240.00k | no data | |
| Independent Non-Executive Director | 8.5yrs | HK$276.00k | no data | |
| Independent Non-Executive Director | 7.8yrs | HK$264.00k | no data | |
| Non Executive Director | 1.4yrs | HK$99.00k | no data |
8.5yrs
Average Tenure
65yo
Average Age
Experienced Board: 1612's board of directors are considered experienced (8.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 07:21 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vincent Medical Holdings Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| E Wuen Tan | Crosby Securities Limited |